Unexpected renal actions of erythropoietin

Experimental Nephrology

Volumn 10, Issue 5-6, 2002, Pages 294-298

  Westenfelder, Christof ^a,b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acute renal failure; Apoptosis; Autosomal dominant polycystic kidney disease; Caspases; Chemokinesis; Erythropoietin; Erythropoietin receptor; Growth factor withdrawal; Kidney cancer; Mitogenesis; Motogenesis

Indexed keywords

CYTOKINE; ERYTHROPOIETIN;

ACUTE KIDNEY FAILURE; CANCER CELL; CELL SURVIVAL; DRUG MECHANISM; HUMAN; IN VITRO STUDY; KIDNEY; KIDNEY CANCER; KIDNEY CELL; KIDNEY CYST; KIDNEY DISTAL TUBULE; KIDNEY EPITHELIUM; KIDNEY ISCHEMIA; KIDNEY POLYCYSTIC DISEASE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MESANGIUM CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; CYTOKINES; ERYTHROPOIETIN; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY NEOPLASMS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; REFERENCE VALUES;

EID: 0036970594     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065304     Document Type: Short Survey

References (35)

1. Jelkmann W: Erythropoietin: Structure, control of production and function. Physiol Rev 1992;72:449-489.
2. Maxwell PH, Osmond MK, Pugh CW, Heryet A, Nicholls LG, Tan CC, Doe BG, Ferguson DJ, Johnson MH, Ratcliffe PJ: Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993;44:1149-1162.
3. Heidenreich S, Rahn KH, Zidek W: Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991;39:259-265.
4. Nushiro N, Sakamaki T, Hoshino J, Nakamura T, Sakamoto H, Imai Y, Seino M, Omata K, Sekino H, Abe K: Recombinant human erythropoietin stimulates tubular reabsorption of sodium in anesthetized rabbits. Hypertens Res 1995;18:203-207.
5. Allon M: Renal abnormalities in sickle cell disease. Arch Intern Med 1990;150:501-504.
6. Kaissling B, Spiess S, Rinne B, Le Hir M: Effects of anemia on morphology of rat renal cortex. Am J Physiol 1993;264:F608-F617.
7. Spivak JL, Watson AJ: Hematopoiesis and the kidney; in Seldin DW, Giebisch G (eds): The Kidney: Physiology and Pathology. New York, Raven Press, 1992 pp 1553-1593.
8. Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish HF: Structure, function and activation of the erythropoietin receptor. Blood 1993;81:2223-2236.
9. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990;87:5978-5982.
10. Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas FJ, Tabira T, Sasaki R: Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 1993;268:11208-11216.
11. Carlini R, Reyes A, Rothstein M: Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995;47:740-745.
12. Sasaki R, Masuda S, Nagao M: Pleiotropic functions and tissue-specific expression of erythropoietin. News Physiol Sci 2001;16:110-113.
13. Damen JE, Krystal G: Early events in erythro-poietin-induced signaling. Exp Hematol 1996;24:1455-1459.
14. Westenfelder C, Biddle DL, Baranowski RL: Human, rat and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999;55:808-820.
15. 2+ channels: Activation by phospholipase Cγ1. Kidney Int 1998;53:1259-1268.
16. Westenfelder C, Sullivan C, Baranowski RL: Mitogenic signaling of erythropoietin in murine renal proximal tubular cells involves STAT5 and c-myc. J Am Soc Nephrol 1998;9:408A.
17. Bacallao R, Fine LG: Molecular events in the organization of renal tubular epithelium: From nephrogenesis to regeneration. Am J Physiol 1989;257:F913-F924.
18. Toback F: Regeneration after acute tubular necrosis. Kidney Int 1992;41:226-246.
19. Westenfelder C, Baranowski RL: Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int 2000;58:647-657.
20. Westenfelder C, Baranowski RL: Erythropoietin exerts an anti-apoptotic effect in normal human proximal tubular cells but not in kidney cancer cells ('786-0') that lack the von Hippel-Lindau tumor suppressor gene. J Am Soc Nephrol 2001;12:623A.
21. Rubins J: Metastatic renal cell carcinoma: Response to treatment with human recombinant erythropoietin. Ann Intern Med 1995;122:676-677.
22. Ljungberg B, Rasmuson T, Grankvist K: Erythropoietin in renal cell carcinoma: Evaluation of its usefulness as a tumor marker. Eur Urol 1992;21:160-163.
23. Fick GM, Gabow PA: Hereditary and acquired cystic disease of the kidney. Kidney Int 1994;46:951-964.
24. Eckardt KU, Mollmann M, Neumann R, Brunkhorst R, Burger HU, Lonnemann G, Scholz H, Keusch G, Buchholz B, Frei U, Bauer C, Kurtz A: Erythropoietin in polycystic kidneys. J Clin Invest 1989;84:1160-1166.
25. Franek E, Kokot F, Wiecek A, Pawlowski W, Myrta J, Szewczyk W, Bar A: Erythropoietin concentration in cyst fluid in patients with simple renal cysts. Nephron 1994;67:431-435.
26. Westenfelder C, Baranowski RL, Soto C, Loghman-Adham M: Immortalized (SV40), cyst-derived epithelial cells in autosomal dominant polycystic kidney disease (ADPKD) retain erythropoietin receptor expression: A suitable model for the study of EPO's potential role in cystogenesis. J Am Soc Nephrol 2000;11:400A.
27. Nielsen O, Thaysen J: Erythropoietin deficiency in acute tubular necrosis. J Intern Med 1990;227:373-380.
28. Wood P, Hrushesky W: Cisplatin-associated anemia: An erythropoietin deficiency syndrome. J Clin Invest 1995;95:1650-1659.
29. Tan CC, Tan LH, Eckardt KU: Erythropoietin production in rats with post-ischemic acute renal failure. Kidney Int 1996;50:1958-1964.
30. Westenfelder C, Baranowski RL, Toback FG: Mitogenic and motogenic actions of erythropoietin on tubular cells appear to accelerate functional recovery from ischemic acute renal failure in rats. J Am Soc Nephrol 2000;11:597A.
31. Juul SE, Yachnis AT, Christensen RD: Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 1998;52:235-249.
32. Westenfelder C, Baranowski RL: Erythropoietin treatment ameliorates ischemic acute renal failure in rats by its anti-apoptotic, motogenic and mitogenic actions. J Am Soc Nephrol 2001;11:793A.
33. Nemoto T, Yokota N, Keane WF, Rabb H: Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int 2001;59:246-251.
34. Vaziri N, Zhou X, Liao S: Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am J Physiol 1994;266:F360-F366.
35. Star RA: Treatment of acute renal failure. Kidney Int 1998;54:1817-1831.